Tuesday, 16 November 2021

No one’s listening: an inquiry into the avoidable deaths and failures of care for sickle cell patients in secondary care

No one’s listening: an inquiry into the avoidable deaths and failures of care for sickle cell patients in secondary care This report, jointly published with the Sickle Cell Society, has found “serious care failings” in acute services and evidence of attitudes underpinned by racism. These concerns have led to a fear and avoidance of hospitals for many people living with sickle cell. The report includes a number of recommendations and the APPG is calling on the Secretary of State for Health and Social Care, NHS England and NHS Improvement to prioritise taking urgent action. All-Party Parliamentary Group on Sickle Cell and Thalassaemia

    See also:

    Government to invest £375 million in neurodegenerative disease research

    Government to invest £375 million in neurodegenerative disease research People living with neurodegenerative diseases could live longer, healthier lives due to innovative new research, following a government commitment to invest £375 million over the next 5 years.

    At least £50 million will be made available specifically for research to help find a cure for MND – a condition that affects the brain and nerves and affects 5,000 people in the UK. New, innovative projects will help researchers to better understand the disease and its related conditions, develop and test treatments and improve care for those living with MND. Department of Health and Social Care

    UK hits 12 million top-ups in record-breaking week

    UK hits 12 million top-ups in record-breaking week More than 2 million boosters have been given to people across the UK in the last week, as the vaccination programme continues to accelerate.

    In a record-breaking week, the UK has topped 12 million booster and third jabs given in total across the UK – with hundreds of thousands of people coming forward every day to get the vital protection offered by top-up jabs ahead of the colder months. Department of Health and Social Care

    See also:

    Over-40s Covid booster due to 'waning' protection

    Over-40s Covid booster due to 'waning' protection Professor Jonathan Van-Tam has said that "waning" protection against Covid, has led to a recommendation that everyone over the age of 40 receives a third booster dose of the vaccine.

    The Joint Committee on Vaccination and Immunisation also recommended that 16 and 17 years olds should receive a second dose. BBC News

    See also: 

    Alarm over ‘serious’ delays in diagnosing childhood cancer in England

    Alarm over ‘serious’ delays in diagnosing childhood cancer in England Health experts have raised the alarm over “serious” delays in diagnosing children and young people with cancer, as a study reveals the number found to have the disease during the pandemic fell by almost a fifth. The Guardian

    NHS bosses advise all hospitals to review security after Liverpool blast

    NHS bosses advise all hospitals to review security after Liverpool blast NHS chiefs are advising all hospitals to review their security arrangements in the wake of Sunday’s terrorist incident at Liverpool Women’s hospital, the Guardian can reveal.

    NHS England is finalising new guidance to send to all 213 health trusts in England, which between them provide services at more than 500 hospital sites. The Guardian 

    Friday, 12 November 2021

    Covid could ‘ruin next five Christmases’ as expert warns jabs are not enough

    Covid could ‘ruin next five Christmases’ as expert warns jabs are not enough Covid-19 could ruin Christmas for the next five years, a leading health expert has warned.

    Professor Tim Spector has said the current vaccine and testing measures are not sufficient enough to keep the spread of the virus under control. Northamptonshire Telegraph

    See also: 

    Two nurses studying in Northampton receive prestigious title for their dedication to the industry

    Two nurses studying in Northampton receive prestigious title for their dedication to the industry Two nurses studying for advanced qualifications in Northampton have received prestigious, national titles for their dedication to the industry. Northampton Chronicle and Echo 

    'They saved my baby': Mum's emotional thank you to Northampton General Hospital

    'They saved my baby': Mum's emotional thank you to Northampton General Hospital First time mum, Charlotte Gould-Leer, 22, was told the chances of saving her extremely premature baby were 'minimal' but, despite the odds, nurses and doctors in Northampton and Coventry were able to save little Christine's life. Northampton Chronicle and Echo 

    NHS performance summary: September-October 2021

    NHS performance summary: September-October 2021 NHS England published the latest data on key activity and performance measures for August and September of this year. Here we show the performance against some key targets, including those set out in the 2021/22 operational planning guidance published in September.

    A&E waiting times in October were the worst since records began, with 1 in 4 patients waiting longer than four hours to be admitted, transferred or discharged. Attendances are back to pre-pandemic levels, and trolley waits are at a record high. Nuffield Trust

    See also:

    New report highlights persistent inequalities and continued inequitable care for pregnant women

    New report highlights persistent inequalities and continued inequitable care for pregnant women The latest Saving Lives, Improving Mothers' Care study examines in detail the care of all women who died during, or up to one year after, pregnancy between 2017 and 2019 in the UK.

    Pregnancy remains very safe in the UK, with the overall maternal death rate showing a slight decrease. Among 2,173,810 women who gave birth in 2017-2019, 191 died during or up to six weeks after pregnancy, and 495 during or up to one year after their pregnancy.

    Nevertheless, the findings show a continued inequality in the mortality rates for women of different ethnic backgrounds, ages, and socio-economic circumstances. MBRRACE

    See also:

    The state of the state 2021-22: towards a new public sector normal

    The state of the state 2021-22: towards a new public sector normal This is Deloitte and Reform's tenth annual report on government and public services. It blends a citizen survey (conducted by Ipsos MORI) with commentary built on interviews with fifty of the most senior figures in government and public services. These officials talked of organisational pressures, the impact of austerity and their concerns over funding for the future. This year's report also includes the views of business leaders on their experience of working alongside the public sector. Deloitte 

    NHS chief announces next steps for local health systems

    NHS chief announces next steps for local health systems The NHS will set out the next steps for how primary care networks will work with partners across newly formed integrated care systems to meet the health needs of people in their local areas.

    NHS chief executive Amanda Pritchard has asked Dr Claire Fuller, senior responsible officer of the Surrey Heartlands Integrated Care System, to set out how systems can accelerate implementation of the primary care, out of hospital care and prevention ambitions in the NHS Long Term Plan and drive more integrated primary, community and social care services at a local level. NHS England 

    Over 11 million people receive top-up COVID-19 vaccine

    Over 11 million people receive top-up COVID-19 vaccine The vital booster programme has reached another milestone as more than 11.4 million people in the UK have now received their top-up jabs to maintain protection ahead of the winter months. Department of Health and Social Care

    See also: 

    Covid: Medication holiday may boost vaccine protection

    Covid: Medication holiday may boost vaccine protection An important trial will test how to boost Covid jab protection in vulnerable patients whose immune systems are weakened by drugs they need for other health conditions.

    About 1.3 million people in the UK are on methotrexate for conditions such as rheumatoid arthritis and psoriasis. BBC News

    See also: 

    Alder Hey NHS Trust must pay boy £27m over brain injuries

    Alder Hey NHS Trust must pay boy £27m over brain injuries A boy who suffered "catastrophic brain injuries" when doctors failed to see he had a virus and sent him home after he had a seizure has been awarded £27m. BBC News 

    Menopause: Bereaved husband urges men to spot mental health signs

    Menopause: Bereaved husband urges men to spot mental health signs A bereaved husband has urged men to recognise signs of mental health symptoms linked to the menopause.

    Linda Salmon, 56, took her own life last April after her anxiety worsened during the Covid pandemic.

    Her husband David said he had not realised the menopause could cause suicidal thoughts. BBC News

    NHS ambulance delays leaving patients stuck at GP surgeries for hours

    NHS ambulance delays leaving patients stuck at GP surgeries for hours Patients experiencing life-threatening emergencies such as heart attacks, strokes or major breathing problems are becoming trapped for many hours in GP surgeries, unable to get to hospital, because ambulances are taking so long to turn up after the GP practice rings 999. The Guardian

    See also: 

    Care home chaos commences as up to 60,000 staff sacked overnight

    Care home chaos commences as up to 60,000 staff sacked overnight A care home manager broke down today after being forced to sack six staff members who refused to get vaccinated against Covid — as she pleaded with Boris Johnson to 'give us a break'. The Daily Mail

    Blood test could identify patients at risk of type 2 diabetes almost 20 YEARS before, study claims

    Blood test could identify patients at risk of type 2 diabetes almost 20 YEARS before, study claims A blood test may detect people at risk of developing type 2 diabetes two decades for the condition strikes, a study suggests.  

    Swedish scientists found people with high levels of a protein called follistatin were twice as likely to develop the 'silent killer', compared to volunteers at the other end of the scale. The Daily Mail

    See also: